Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
March 3, 2026
Determination of antigen components in inactivated SARS-CoV-2 vaccine using ultra-high-performance liquid chromatography tandem mass spectrometry
JS
Jiexia Shi
Guangzhou Center for Disease Control and Prevention
FD
Fenfang Deng
Guangzhou Center for Disease Control and Prevention
YL
Yongxian Li
Ver todo
Puntos clave
The analysis reveals key antigen components of the inactivated SARS-CoV-2 vaccine, enhancing understanding of immune responses.
Using ultra-high-performance liquid chromatography tandem mass spectrometry, specific components were accurately identified.
The research highlights the importance of identifying antigen profiles for effective vaccine development and optimization.
These findings may lead to improved vaccine formulations and effectiveness in combating COVID-19.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Shi et al. (Mon,) studied this question.
synapsesocial.com/papers/69a765bcbadf0bb9e87da390
https://doi.org/https://doi.org/10.1016/j.jpba.2026.117388
Determination of antigen components in inactivated SARS-CoV-2 vaccine using ultra-high-performance liquid chromatography tandem mass spectrometry | Synapse